Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BPH Energy Limited ( (AU:BPH) ) has shared an update.
BPH Energy Limited’s December 2025 quarter report outlines several capital management moves, including issuing shares to settle advertising fees, the expiry of more than 622 million unexercised options, the launch of a replacement series of options for existing holders and directors to maintain participation in the company’s development, and the exercise and new issuance of a smaller parcel of director options. Operationally, the company’s key investee Advent Energy continues to contest the refusal of applications related to the PEP-11 offshore petroleum permit, with a Federal Court judicial review now scheduled for February 2026 while the permit remains in force and in compliance, a process that could shape the future of its offshore exploration interests. Another investee, Cortical Dynamics, advanced its next-generation AI-enhanced BARM 2.0 brain and pain monitoring system towards technical completion, planned clinical trials in the USA and Netherlands, and showcased the technology at major regulatory and industry forums in Sydney and Canberra, while continuing development of its CORDYAN AI predictive medical app platform, reinforcing BPH’s exposure to emerging medtech innovation alongside its energy investments.
The most recent analyst rating on (AU:BPH) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on BPH Energy Limited stock, see the AU:BPH Stock Forecast page.
More about BPH Energy Limited
BPH Energy Limited is an Australian investment company with interests in energy and medical technology, holding stakes in Advent Energy Limited, which is focused on offshore oil and gas exploration, and Cortical Dynamics Limited, a medtech developer of AI-enhanced brain and pain monitoring systems. The company’s portfolio targets high-risk, high-reward sectors including offshore petroleum permits and advanced medical devices aimed at improving surgical outcomes and healthcare efficiency.
Average Trading Volume: 3,564,458
Technical Sentiment Signal: Sell
Current Market Cap: A$14.89M
Find detailed analytics on BPH stock on TipRanks’ Stock Analysis page.